Recent advances in the development of anti-infective prophylactic and/or therapeutic agents based on Toll-Like Receptor (TLRs).

@article{Junquera2014RecentAI,
  title={Recent advances in the development of anti-infective prophylactic and/or therapeutic agents based on Toll-Like Receptor (TLRs).},
  author={Elena Junquera and Lourdes Mateos-Hern{\'a}ndez and Jos{\'e} de la Fuente and Jos{\'e} Manuel P{\'e}rez de la Lastra},
  journal={Recent patents on anti-infective drug discovery},
  year={2014},
  volume={9 1},
  pages={14-24}
}
Toll-like receptors (TLRs) are key players in innate immunity. They are able to sense different microorganisms ranging from protozoa to bacteria, fungi or viruses. Innate immune responses can directly influence adaptive immune responses. Therefore, TLRs are considered as relevant targets for therapeutic applications in immune diseases: such as autoimmune disorders, allergy, sepsis, and cancer. We here review the recent patents based on the modulation of the toll-like receptors to develop anti… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS